Inventiva (IVA) Q2 2026 Earnings Call Transcript
Lanifibranor Phase III results expected Q4 2026, potential FDA submission H1 2027.
We haven't written up this one. Motley Fool has the full story — the link below goes straight to it.
More in Finance & Markets
Dangote says refinery IPO will democratise wealth creation
Dangote said the planned listing is part of a wider strategy to spread ownership of his businesses among the public, allowing investors to earn dividends and benefit from potential increases in the…
Finance Minister holds talks with counterparts from Tanzania, Nepal and Bangladesh
His Excellency Minister of Finance Ali bin Ahmed Al Kuwari held separate meetings with his counterparts from Tanzania, Nepal and Bangladesh on the sidelines of the 2026 annual meeting of the Asian…
Pakistan Stock Brokers Association Elects New Directors
The Pakistan Stock Brokers Association (PSBA) has officially notified Muhammad Yasir Mahmoud as its new chairman during its Annual General … Read More The post Pakistan Stock Brokers Association…
AFRICA FINANCE IN BRIEF: Botswana second downgrade, Ghana’s new cedi and fresh inflation risks
Here are the stories shaping Africa’s financial markets, economies and businesses this week — from Botswana’s weakening diamond revenues and read more AFRICA FINANCE IN BRIEF: Botswana second…
NNPC’s profit rises 33% to N7.2tn, remits N22.3tn to government
The Nigerian National Petroleum Company Limited has announced a 33% increase in its profit after tax to N7.2tn for the 2025 financial year.
How Kaduna raked in N220bn tax through dialogue — Finance commissioner
Kaduna State generated N220bn in tax revenue between 2023 and 2025 through dialogue and stakeholder engagement, says Finance Commissioner Mohammed Tanko.